Background: It has been observed that formerly rejected opaque corneal transplants can regain clarity in the rat. We hypothesized that graft endothelium is regenerated by the host. Therefore, we used green fluorescent protein (GFP) transgenic rats to assess the origin of cells following keratoplasty. Methods: Allogeneic corneal transplantations were carried out between Fischer strain rats as graft donors and GFP-transgenic Lewis rats as recipients. In a second group, syngeneic transplantations were performed between GFP-negative Lewis donors and GFP-positive Lewis recipients, where endothelial-cell-free grafts after mechanical endothelial debridement were used. All grafts were followed up clinically for signs of opacity and rejection. After 6 weeks, corneal flatmounts counterstained with DAPI were analyzed by confocal microscopy. Results: Syngeneic transplantation of endothelial-cell-free grafts led to medium opacity levels without rejection and to subsequent clearing. All grafts showed a population of GFP-positive, host-derived endothelial cells on the graft after 6 weeks. In the allogeneic transplantation group, all grafts but one were rejected after a median of 17 days. While the graft that was not rejected maintained the GFP-negative transplant endothelium, all formerly rejected grafts showed GFP-positive endothelium on the transplant after 6 weeks, accompanied by clinical clearing of the graft. Conclusion: GPF positivity shows that in both a syngeneic and an allogeneic setting, the host-derived corneal endothelium can compensate for the endothelial cell loss of the graft. Following rejection, the grafts are repopulated by host-derived endothelial cells in the rat. This finding demonstrates a high regenerative capacity of the peripheral corneal endothelium in the rat, which should be considered whenever interpreting rat keratoplasty results.

Keywords:
Corneal transplants, Rat keratoplasty, Endothelial cells, Green fluorescent protein
1.
Plšková J, Kuffová L, Holáň V, Filipec M, Forrester JV: Evaluation of corneal graft rejection in a mouse model. Br J Ophthalmol 2002;86:108-113.
2.
Gong N, Pleyer U, Ritter T, Knop E, Chen X: Corneal allograft endothelial cell replacement represents a reparative response to transplant injury. Mol Vis 2009;15:654-661.
3.
Schwartzkopff J, Bredow L, Mahlenbrey S, Boehringer D, Reinhard T: Regeneration of corneal endothelium following complete endothelial cell loss in rat keratoplasty. Mol Vis 2010;16:2368-2375.
4.
Inoue H, Ohsawa I, Murakami T, Kimura A, Hakamata Y, Sato Y, et al: Development of new inbred transgenic strains of rats with LacZ or GFP. Biochem Biophys Res Commun 2005;329:288-295.
5.
Langenbucher A, Seitz B, Nguyen NX, Naumann GO: Corneal endothelial cell loss after nonmechanical penetrating keratoplasty depends on diagnosis: a regression analysis. Graefes Arch Clin Exp Ophthalmol 2002;240:387-392.
6.
Böhringer D, Böhringer S, Poxleitner K, Birnbaum F, Schwartzkopff J, Maier P, et al: Long-term graft survival in penetrating keratoplasty: the biexponential model of chronic endothelial cell loss revisited. Cornea 2010;29:1113-1117.
7.
Tuft SJ, Williams KA, Coster DJ: Endothelial repair in the rat cornea. Invest Ophthalmol Vis Sci 1986;27:1199-1204.
8.
Hori J, Streilein JW: Dynamics of donor cell persistence and recipient cell replacement in orthotopic corneal allografts in mice. Invest Ophthalmol Vis Sci 2001;42:1820-1828.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.